Abbott collaborates with Nutrition Society of India to create awareness on clinical dietary recommendations for GI patients ruchika13 March 2021 4:00 AM GMTKolkata: Metabolic syndrome and associated gastrointestinal (GI) conditions are becoming increasingly prevalent in the country with 33.5% of India...
Include more govt sites for Phase III clinical trial of Ursodeoxycholic Acid Tablets: CDSCO panel to Abbott MD Bureau28 Feb 2021 5:45 AM GMTNew Delhi: Suggesting to include more government sites in Phase III Clinical trial protocol, the Central Drugs Standard Control Organization (CDSCO) Co...
Abbott launches Pedialyte Hydration Solution to support immune health ruchika17 Dec 2020 5:30 AM GMTPedialyte with Immune Support is one of four new Pedialyte products designed to meet a variety of hydration needs and easily found in the pharmacy...
Abbott launches clip delivery system to treat mitral regurgitation in India ruchika19 Nov 2020 6:28 AM GMTThis clip device repairs leaky mitral valves without open-heart surgery and is delivered to the heart through a vein in the leg.
Glucose Monitoring for Diabetics: Abbott launches FreeStyle Libre System in India ruchika3 Nov 2020 7:56 AM GMTThe FreeStyle Libre sensor measures glucose every minute in interstitial fluid through a small (5.5mm long) filament that is inserted just under the...
Abbott launches heart rhythm management devices ICD, CRT-D in India ruchika15 Oct 2020 6:30 AM GMTThe devices offer new opportunities for patient engagement and remote monitoring through smartphone connectivity and connected applications, it added.
DCGI green flag to Abbott heart failure, angina treatment drug Ivabradine Farhat Nasim3 Sep 2020 11:24 AM GMTAbbott plans to launch Ivabradine prolonged-release tablets in the Indian market in the coming weeks.
Abbott rapid Covid-19 test kit gets USFDA nod for emergency use ruchika28 Aug 2020 10:54 AM GMTAbbott will also launch a complementary mobile app for iPhone and Android devices named NAVICA that will allow people to display their results...
Health Ministry calls for immediate action against Abbott, Danone over alleged violation of IMS Act Farhat Nasim22 Aug 2020 7:29 AM GMTNew Delhi: In a major setback to drug giant, Abbott, and international food major Danone; the Union Health Ministry has pulled the baby food makers and...
Abbott sees no hit to demand for COVID-19 tests from vaccine ruchika19 July 2020 4:00 AM GMT'It's clear that the need for testing is large and it isn't going away,' Chief Executive Officer Robert Ford said on a post-earnings conference call.
Indian stent maker giant SMT to sell 30 percent stake for Rs 1100 crores Farhat Nasim14 July 2020 12:24 PM GMTPart of the funds raised from the stake sale will be used for clinical trials in the US and for building a Rs 250 crore manufacturing plant in...
Ensure production, adequate stock of methylprednisolone, heparin, dexamethasone: NPPA directs pharma cos ruchika10 July 2020 11:19 AM GMTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has directed State Drug Controllers (SDCs) to issue...
